Targeted mitochondrial drugs for treatment of myocardial ischaemia-reperfusion injury

被引:3
|
作者
Peng, Jin-Fu [1 ,2 ]
Salami, Oluwabukunmi Modupe [3 ]
Lei, Cai [2 ]
Ni, Dan [2 ]
Habimana, Olive [3 ]
Yi, Guang-Hui [1 ,2 ]
机构
[1] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Inst Pharm & Pharmacol, Hengyang, Peoples R China
[2] Univ South China, Hengyang Med Sch, Hunan Int Sci & Technol Cooperat Base Arterioscle, Inst Cardiovasc,Dis Key Lab Arteriosclerotic Dis, 28 Changsheng West Rd, Hengyang 421001, Peoples R China
[3] Univ South China, Internat Coll, Hengyang, Peoples R China
关键词
Myocardial ischaemia-reperfusion injury; targeting mitochondrial quality control; targeting mitochondrial quantity control; targeted mitochondrial drugs; POST-CONDITIONING PROTECTS; ISCHEMIA/REPERFUSION INJURY; THERAPEUTIC TARGET; QUALITY-CONTROL; FISSION; DYNAMICS; MECHANISMS; FUSION; CARDIOPROTECTION; SALIDROSIDE;
D O I
10.1080/1061186X.2022.2085728
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Myocardial ischaemia-reperfusion injury (MI/RI) refers to the further damage done to ischaemic cardiomyocytes when restoring blood flow. A large body of evidence shows that MI/RI is closely associated with excessive production of mitochondrial reactive oxygen species, mitochondrial calcium overload, disordered mitochondrial energy metabolism, mitophagy, mitochondrial fission, and mitochondrial fusion. According to the way it affects mitochondria, it can be divided into mitochondrial quality abnormalities and mitochondrial quantity abnormalities. Abnormal mitochondrial quality refers to the dysfunction caused by the severe destruction of mitochondria, which then affects the balance of mitochondrial density and number, causing an abnormal mitochondrial quantity. In the past, most of the reports were limited to the study of the mechanism of myocardial ischaemia-reperfusion injury, some of which involved mitochondria, but no specific countermeasures were proposed. In this review, we outline the mechanisms for treating myocardial ischaemia-reperfusion injury from the direction of mitochondria and focus on targeted interventions and drugs to restore mitochondrial health during abnormal mitochondrial quality control and abnormal mitochondrial quantity control. This is an update in the field of myocardial ischaemia-reperfusion injury.
引用
收藏
页码:833 / 844
页数:12
相关论文
共 50 条
  • [21] TNF-α treatment and cerebral ischaemia-reperfusion injury
    Wu, Y
    Liang, Q
    Lv, H
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (04): : 609 - 609
  • [22] Targeted Mitochondrial Drugs for Treatment of Ischemia-Reperfusion Injury
    Peng, Jin-Fu
    Salami, Oluwabukunmi Modupe
    Habimana, Olive
    Xie, Yu-Xin
    Yao, Hui
    Yi, Guang-Hui
    CURRENT DRUG TARGETS, 2022, 23 (16) : 1526 - 1536
  • [23] Exercise and myocardial tolerance to ischaemia-reperfusion
    Lennon, SL
    Quindry, JC
    French, JP
    Kim, S
    Mehta, JL
    Powers, SK
    ACTA PHYSIOLOGICA SCANDINAVICA, 2004, 182 (02): : 161 - 169
  • [24] Complement in ischaemia-reperfusion injury and transplantation
    Howard, Mark C.
    Nauser, Christopher L.
    Farrar, Conrad A.
    Sacks, Steven H.
    SEMINARS IN IMMUNOPATHOLOGY, 2021, 43 (06) : 789 - 797
  • [25] microRNA regulatory mechanisms of mitoKATP in myocardial ischaemia-reperfusion injury in rats
    Nie, J.
    Deng, M.
    Wang, H.
    Yu, T.
    BRITISH JOURNAL OF ANAESTHESIA, 2019, 122 (03) : E35 - E36
  • [26] Phosphorylation status of matrix metalloproteinase 2 in myocardial ischaemia-reperfusion injury
    Sariahmetoglu, Meltem
    Skrzypiec-Spring, Monika
    Youssef, Nermeen
    Jacob-Ferreira, Anna Laura B.
    Sawicka, Jolanta
    Holmes, Charles
    Sawicki, Grzegorz
    Schulz, Richard
    HEART, 2012, 98 (08) : 656 - 662
  • [27] THE EFFECT OF DIABETES ON PROTECTION OF ISCHAEMIC POSTCONDITIONING IN MYOCARDIAL ISCHAEMIA-REPERFUSION INJURY
    Zhao Xin
    Yu Xuefan
    Quan Nanhu
    HEART, 2010, 96 : A40 - A40
  • [28] ENDOGENOUS PROTECTION AGAINST MYOCARDIAL ISCHAEMIA-REPERFUSION INJURY IN THE DIABETIC HEART
    Whittington, H. J.
    McLaughlin, C. P.
    Hausenloy, D. J.
    Yellon, D. M.
    Mocanu, M. M.
    HEART, 2011, 97 (24)
  • [29] Effect of levosimendan on erythrocyte deformability during myocardial ischaemia-reperfusion injury
    Arslan, M.
    Comu, F. M.
    Alkan, M.
    Kiraz, H. A.
    Kip, G.
    Ozer, A.
    Sivgin, V
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2015, 116 (01): : 47 - 50
  • [30] Hyperglycaemia and renal ischaemia-reperfusion injury
    Melin, J
    Hellberg, O
    Fellström, B
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (03) : 460 - 462